A study was conducted to evaluate vitamin VC, VK3, and the VC/VK3 combinations for their antitumor activity against human bladder (T24) and ovarian carcinoma (MDAH) cell lines. Overall morphological changes were documented and compared to the observations of LM and SEM. Changes at the subcellular level were also determined.
|Number of pages||2|
|Publication status||Published - Mar 2000|